What is Winpro?
Established in 2016 and headquartered in Des Moines, Iowa, Winpro occupies a distinct niche within the pet health industry. The company distinguishes itself as the sole provider of blood protein supplements specifically formulated for canine health. By leveraging proprietary formulations, Winpro addresses specific physiological needs in dogs, positioning itself as a high-growth player in the premium pet nutrition sector. Its market position is defined by a commitment to scientific rigor and a specialized product line that differentiates it from traditional supplement manufacturers.
How much funding has Winpro raised?
Winpro has raised a total of $3M across 1 funding round:
Series B
$3M
Series B (2021): $3M with participation from Next Level Ventures
Key Investors in Winpro
Next Level Ventures
Next Level Ventures is a prominent investment firm based in Iowa, managing over $400 million in assets across a diverse portfolio of more than 45 companies. The firm specializes in providing strategic investments ranging from seed funding to growth-stage funding, with typical investments between $0.5 to $5.0 million.
What's next for Winpro?
Following this major strategic investment, Winpro is well-positioned to scale its operational footprint and expand its distribution channels. The capital infusion will likely facilitate deeper market penetration and the potential development of new product iterations within the canine health vertical. As the company transitions from its current growth phase, the focus will remain on maintaining its competitive advantage in the blood protein supplement space while scaling its supply chain to meet increasing demand. The backing from institutional partners provides the necessary runway to accelerate brand awareness and solidify its status as a leader in the pet wellness ecosystem.
See full Winpro company page
